{"id":1411,"date":"2024-12-28T08:58:14","date_gmt":"2024-12-28T03:28:14","guid":{"rendered":"https:\/\/gaainfo.com\/?p=1411"},"modified":"2024-12-28T08:58:14","modified_gmt":"2024-12-28T03:28:14","slug":"marksans-pharma-share-price-target","status":"publish","type":"post","link":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/","title":{"rendered":"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results"},"content":{"rendered":"<p>Marksans Pharma is a pioneer in the pharmaceutical industry thanks to its customer-first approach. Marksans has made a name for itself in competitive regulatory markets by focusing on both prescription and over-the-counter medications. Indian pharmaceutical company Marksans Pharma Limited As its primary activity, it is involved in the production and distribution of pharmaceutical formulations for research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2025-2030\"><\/span>Marksans Pharma Share Price Target 2025-2030<span class=\"ez-toc-section-end\"><\/span><\/h2><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_69_1 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Main Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #63d611;color:#63d611\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #63d611;color:#63d611\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2025-2030\" title=\"Marksans Pharma Share Price Target 2025-2030\">Marksans Pharma Share Price Target 2025-2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_Today_Update\" title=\"Marksans Pharma Share Price Target Today Update\">Marksans Pharma Share Price Target Today Update<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Business_Profile\" title=\"Marksans Pharma Business Profile\">Marksans Pharma Business Profile<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Operation\" title=\"Operation\">Operation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#New_Products_List\" title=\"New Products List\">New Products List<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Subsidiaries\" title=\"Subsidiaries\">Subsidiaries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Fundamentals_Quarterly_Results\" title=\"Marksans Pharma Fundamentals &amp; Quarterly Results\">Marksans Pharma Fundamentals &amp; Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Quarterly_Results\" title=\"Marksans Pharma Quarterly Results\">Marksans Pharma Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#CAGR_Report\" title=\"CAGR Report\">CAGR Report<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Shareholding_Pattern\" title=\"Marksans Pharma\u00a0Shareholding Pattern\">Marksans Pharma\u00a0Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2025-2030_Forecast\" title=\"Marksans Pharma Share Price Target 2025-2030 Forecast\">Marksans Pharma Share Price Target 2025-2030 Forecast<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2025\" title=\"Marksans Pharma Share Price Target 2025\">Marksans Pharma Share Price Target 2025<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2026\" title=\"Marksans Pharma Share Price Target 2026\">Marksans Pharma Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2027\" title=\"Marksans Pharma Share Price Target 2027\">Marksans Pharma Share Price Target 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2028\" title=\"Marksans Pharma Share Price Target 2028\">Marksans Pharma Share Price Target 2028<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2029\" title=\"Marksans Pharma Share Price Target 2029\">Marksans Pharma Share Price Target 2029<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Marksans_Pharma_Share_Price_Target_2030\" title=\"Marksans Pharma Share Price Target 2030\">Marksans Pharma Share Price Target 2030<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#Final_Words\" title=\"Final Words\">Final Words<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p>Marksans Pharma ltd is a company that has been listed on stock exchanges and focuses primarily on its core business. The company&#8217;s performance on the stock exchange has been improving, which has led to an increase in the share price as well. This is due to the company&#8217;s reputation\u2014the goodwill it has gained over time. The company&#8217;s performance in the pharmaceutical industry and the trust that customers place in it when purchasing various medicines contribute to its goodwill.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_Today_Update\"><\/span>Marksans Pharma Share Price Target Today Update<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Marksans Pharma Ltd. can be a profitable investment choice if you&#8217;re looking for stocks with a high return. At 2025-08-21, the Marksans Pharma Ltd. quote is equivalent to 220.900 INR. The &#8220;Marksans Pharma Ltd&#8221; stock price outlook for 2029-08-17 is 374.382 Indian Rupees, and our projections indicate a long-term increase. The revenue is expected to be around +69.48% after a five-year investment. In 2029, your current $100 investment could reach $169.48.<\/p>\n<p><strong>Read More:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/redington-share-price-target\/\"><u>Redington Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/infosys-share-price-target\/\"><u>Infosys Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Business_Profile\"><\/span>Marksans Pharma Business Profile<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Marksans Pharma is a manufacturer of pharmaceutical formulations. It is most interested in over-the-counter and prescription drugs, which are widely used in a wide range of applications like treating cancer, stomach infections, diabetes, inflammations, heart problems, and painkillers, among other things.<\/p>\n<ul>\n<li><strong>Product Portfolio:<\/strong> The business has more than one thousand five hundred stocking units and more than three hundred products in various formulations, including plain, enteric-coated, and film-coated tablets, hard and soft gelatin capsules, oral liquids or ointments, and gelatin capsules.<\/li>\n<li><strong>Acquisition &amp; Capex:<\/strong> Marksans acquired Teva&#8217;s manufacturing unit in April 2023 with the intention of increasing its capacity by 200 crores of rupees in total capital expenditure. The company was already working on preacquisition of Rs. 160 crores for FY24, which included Rs. 78 crores in acquisition costs for Capex FY23, which totaled approximately 53 crores.<\/li>\n<li><strong>New Approval:<\/strong> The Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC) received FDA approval on October 23. The Nexium 24 HR Delayed Release Capsules, in the words of AstraZeneca Pharmaceuticals LP, are bioidentical. The new medication will be manufactured in Goa.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Operation\"><\/span>Operation<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li><strong>USA \u2013<\/strong> Co bought Time Cap Labs Inc. in June 2015. The region is served by this specific WoS. Over 50 items are included on the list of their Private Label OTC and Generic Prescription Drug product lines. Target, Walmart, Walgreens, and Kroger, among others, have customers.<\/li>\n<li><strong>UK and Europe- <\/strong>Relonchem and Bells Healthcare, both owned by The Co., provide services to the region. In the United Kingdom, the majority of private label and branded cough liquids come from Bells Healthcare, the largest manufacturer, while Relonchem offers a wide range of own-label healthcare pharmaceutical products. The company has formed partnerships with prominent UK retailers such as Tesco, Asda, Morrisons, Coop, and Boots, resulting in increased distribution and market penetration.<\/li>\n<li><strong>Australia and New Zealand \u2013 <\/strong>Marksans Pharma collaborates with Woolworths Ltd., Coles Mayer Ltd., Aldis, Metcash, and Fauldings, as well as with Teva and Arrow Pharma through a partnership for the New Zealand pharmaceutical market.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"New_Products_List\"><\/span>New Products List<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li><strong>USA \u2013<\/strong> 32 products are in the pipeline, 20 are oral solids, 12 are ointments and creams, 4 are Softgels.<\/li>\n<li><strong>UK \u2013<\/strong> Planned 34 new filings in next 3 yrs. + 16 products awaiting approval.<\/li>\n<li><strong>Australia and New Zealand \u2013<\/strong> 10 products are in the pipeline and expected to be launched over the next 2 yrs.<\/li>\n<li><strong>ROW \u2013<\/strong> 124 products approved, 120 awaiting, approval &amp; 108 in the pipeline.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Subsidiaries\"><\/span>Subsidiaries<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ol>\n<li>Marksans Holdings Ltd (UK) \u2013 WOS<br \/>\n2.\u00a0 Marksans Pharma Inc (US) \u2013 WOS<br \/>\n3.\u00a0 Nova Pharmaceuticals Australasia Pty Ltd. (Australia) \u2013 60% stake<br \/>\n4.\u00a0 Access Healthcare for Medical Products LLC (UAE) \u2013 WOS<\/li>\n<\/ol>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Fundamentals_Quarterly_Results\"><\/span>Marksans Pharma Fundamentals &amp; Quarterly Results<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 1301px;\" width=\"727\">\n<tbody>\n<tr>\n<td>Market Cap<\/td>\n<td>\u20b9 7,509 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Current Price<\/td>\n<td>\u20b9 166<\/td>\n<\/tr>\n<tr>\n<td>High \/ Low<\/td>\n<td>\u20b9 186 \/ 70.2<\/td>\n<\/tr>\n<tr>\n<td>Stock P\/E<\/td>\n<td>23.7<\/td>\n<\/tr>\n<tr>\n<td>Book Value<\/td>\n<td>\u20b9 41.4<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.30 %<\/td>\n<\/tr>\n<tr>\n<td>ROCE<\/td>\n<td>22.2 %<\/td>\n<\/tr>\n<tr>\n<td>ROE<\/td>\n<td>18.6 %<\/td>\n<\/tr>\n<tr>\n<td>Face Value<\/td>\n<td>\u20b9 1.00<\/td>\n<\/tr>\n<tr>\n<td>Debt to equity<\/td>\n<td>0.06<\/td>\n<\/tr>\n<tr>\n<td>Debt Capacity<\/td>\n<td>0.14<\/td>\n<\/tr>\n<tr>\n<td>Debt preceding year<\/td>\n<td>\u20b9 111 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Debt<\/td>\n<td>\u20b9 111 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Reserves<\/td>\n<td>\u20b9 1,830 Cr.<\/td>\n<\/tr>\n<tr>\n<td>EPS<\/td>\n<td>\u20b9 7.00<\/td>\n<\/tr>\n<tr>\n<td>EPS last year<\/td>\n<td>\u20b9 5.88<\/td>\n<\/tr>\n<tr>\n<td>Pledged percentage<\/td>\n<td>0.00 %<\/td>\n<\/tr>\n<tr>\n<td>FCF Prev Ann<\/td>\n<td>\u20b9 53.0 Cr.<\/td>\n<\/tr>\n<tr>\n<td>EVEBITDA<\/td>\n<td>13.8<\/td>\n<\/tr>\n<tr>\n<td>Industry PE<\/td>\n<td>27.0<\/td>\n<\/tr>\n<tr>\n<td>PEG Ratio<\/td>\n<td>0.46<\/td>\n<\/tr>\n<tr>\n<td>Piotroski score<\/td>\n<td>7.00<\/td>\n<\/tr>\n<tr>\n<td>Earnings yield<\/td>\n<td>6.30 %<\/td>\n<\/tr>\n<tr>\n<td>Sales growth 5Years<\/td>\n<td>15.2 %<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Read More:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/emote-electric-surge-bike\/\"><u>Emote Electric Surge Bike<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/triumph-thruxton-400-bike\/\"><u>Triumph Thruxton 400 Bike<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Quarterly_Results\"><\/span>Marksans Pharma Quarterly Results<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Metric<\/td>\n<td>Dec 2020<\/td>\n<td>Mar 2021<\/td>\n<td>Jun 2021<\/td>\n<td>Sep 2021<\/td>\n<td>Dec 2021<\/td>\n<td>Mar 2022<\/td>\n<td>Jun 2022<\/td>\n<td>Sep 2022<\/td>\n<td>Dec 2022<\/td>\n<td>Mar 2023<\/td>\n<td>Jun 2023<\/td>\n<td>Sep 2023<\/td>\n<td>Dec 2023<\/td>\n<\/tr>\n<tr>\n<td>Sales<\/td>\n<td>358<\/td>\n<td>330<\/td>\n<td>349<\/td>\n<td>361<\/td>\n<td>363<\/td>\n<td>418<\/td>\n<td>434<\/td>\n<td>453<\/td>\n<td>480<\/td>\n<td>486<\/td>\n<td>500<\/td>\n<td>531<\/td>\n<td>586<\/td>\n<\/tr>\n<tr>\n<td>Expenses<\/td>\n<td>267<\/td>\n<td>235<\/td>\n<td>272<\/td>\n<td>301<\/td>\n<td>305<\/td>\n<td>354<\/td>\n<td>361<\/td>\n<td>372<\/td>\n<td>403<\/td>\n<td>376<\/td>\n<td>398<\/td>\n<td>417<\/td>\n<td>453<\/td>\n<\/tr>\n<tr>\n<td>Operating Profit<\/td>\n<td>91<\/td>\n<td>95<\/td>\n<td>77<\/td>\n<td>60<\/td>\n<td>58<\/td>\n<td>64<\/td>\n<td>73<\/td>\n<td>80<\/td>\n<td>77<\/td>\n<td>110<\/td>\n<td>102<\/td>\n<td>114<\/td>\n<td>133<\/td>\n<\/tr>\n<tr>\n<td>OPM %<\/td>\n<td>25%<\/td>\n<td>29%<\/td>\n<td>22%<\/td>\n<td>17%<\/td>\n<td>16%<\/td>\n<td>15%<\/td>\n<td>17%<\/td>\n<td>18%<\/td>\n<td>16%<\/td>\n<td>23%<\/td>\n<td>20%<\/td>\n<td>21%<\/td>\n<td>23%<\/td>\n<\/tr>\n<tr>\n<td>Other Income<\/td>\n<td>-3<\/td>\n<td>6<\/td>\n<td>6<\/td>\n<td>9<\/td>\n<td>12<\/td>\n<td>15<\/td>\n<td>16<\/td>\n<td>14<\/td>\n<td>18<\/td>\n<td>11<\/td>\n<td>10<\/td>\n<td>19<\/td>\n<td>5<\/td>\n<\/tr>\n<tr>\n<td>Interest<\/td>\n<td>2<\/td>\n<td>3<\/td>\n<td>1<\/td>\n<td>2<\/td>\n<td>1<\/td>\n<td>5<\/td>\n<td>2<\/td>\n<td>3<\/td>\n<td>2<\/td>\n<td>2<\/td>\n<td>2<\/td>\n<td>2<\/td>\n<td>3<\/td>\n<\/tr>\n<tr>\n<td>Depreciation<\/td>\n<td>9<\/td>\n<td>1<\/td>\n<td>7<\/td>\n<td>7<\/td>\n<td>9<\/td>\n<td>21<\/td>\n<td>11<\/td>\n<td>14<\/td>\n<td>13<\/td>\n<td>14<\/td>\n<td>14<\/td>\n<td>18<\/td>\n<td>22<\/td>\n<\/tr>\n<tr>\n<td>Profit before tax<\/td>\n<td>78<\/td>\n<td>97<\/td>\n<td>75<\/td>\n<td>60<\/td>\n<td>60<\/td>\n<td>53<\/td>\n<td>76<\/td>\n<td>78<\/td>\n<td>79<\/td>\n<td>104<\/td>\n<td>97<\/td>\n<td>114<\/td>\n<td>113<\/td>\n<\/tr>\n<tr>\n<td>Tax %<\/td>\n<td>24%<\/td>\n<td>18%<\/td>\n<td>16%<\/td>\n<td>23%<\/td>\n<td>20%<\/td>\n<td>44%<\/td>\n<td>21%<\/td>\n<td>23%<\/td>\n<td>21%<\/td>\n<td>21%<\/td>\n<td>27%<\/td>\n<td>26%<\/td>\n<td>26%<\/td>\n<\/tr>\n<tr>\n<td>Net Profit<\/td>\n<td>59<\/td>\n<td>80<\/td>\n<td>63<\/td>\n<td>46<\/td>\n<td>48<\/td>\n<td>30<\/td>\n<td>60<\/td>\n<td>60<\/td>\n<td>62<\/td>\n<td>83<\/td>\n<td>70<\/td>\n<td>84<\/td>\n<td>83<\/td>\n<\/tr>\n<tr>\n<td>EPS in Rs<\/td>\n<td>1.44<\/td>\n<td>1.94<\/td>\n<td>1.53<\/td>\n<td>1.11<\/td>\n<td>1.18<\/td>\n<td>0.69<\/td>\n<td>1.46<\/td>\n<td>1.51<\/td>\n<td>1.57<\/td>\n<td>1.81<\/td>\n<td>1.52<\/td>\n<td>1.84<\/td>\n<td>1.84<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"CAGR_Report\"><\/span>CAGR Report<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Compounded Sales Growth:<\/strong><\/p>\n<table style=\"height: 272px;\" width=\"482\">\n<tbody>\n<tr>\n<td>Time Period<\/td>\n<td>Growth Rate<\/td>\n<\/tr>\n<tr>\n<td>10 Years<\/td>\n<td>16%<\/td>\n<\/tr>\n<tr>\n<td>5 Years<\/td>\n<td>15%<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>18%<\/td>\n<\/tr>\n<tr>\n<td>TTM<\/td>\n<td>18%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Compounded Profit Growth:<\/strong><\/p>\n<table style=\"height: 280px;\" width=\"389\">\n<tbody>\n<tr>\n<td>Time Period<\/td>\n<td>Growth Rate<\/td>\n<\/tr>\n<tr>\n<td>10 Years<\/td>\n<td>19%<\/td>\n<\/tr>\n<tr>\n<td>5 Years<\/td>\n<td>52%<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>30%<\/td>\n<\/tr>\n<tr>\n<td>TTM<\/td>\n<td>51%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Stock Price CAGR:<\/strong><\/p>\n<table style=\"height: 308px;\" width=\"474\">\n<tbody>\n<tr>\n<td>Time Period<\/td>\n<td>CAGR<\/td>\n<\/tr>\n<tr>\n<td>10 Years<\/td>\n<td>20%<\/td>\n<\/tr>\n<tr>\n<td>5 Years<\/td>\n<td>48%<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>30%<\/td>\n<\/tr>\n<tr>\n<td>1 Year<\/td>\n<td>126%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Return on Equity:<\/strong><\/p>\n<table style=\"height: 291px;\" width=\"752\">\n<tbody>\n<tr>\n<td>Time Period<\/td>\n<td>ROE<\/td>\n<\/tr>\n<tr>\n<td>10 Years<\/td>\n<td>20%<\/td>\n<\/tr>\n<tr>\n<td>5 Years<\/td>\n<td>21%<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>22%<\/td>\n<\/tr>\n<tr>\n<td>Last Year<\/td>\n<td>19%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Shareholding_Pattern\"><\/span>Marksans Pharma\u00a0Shareholding Pattern<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Shareholder Type<\/td>\n<td>Sep 2022<\/td>\n<td>Dec 2022<\/td>\n<td>Mar 2023<\/td>\n<td>Jun 2023<\/td>\n<td>Sep 2023<\/td>\n<td>Dec 2023<\/td>\n<td>Mar 2025<\/td>\n<\/tr>\n<tr>\n<td>Promoters<\/td>\n<td>48.60%<\/td>\n<td>49.00%<\/td>\n<td>43.85%<\/td>\n<td>43.85%<\/td>\n<td>43.85%<\/td>\n<td>43.85%<\/td>\n<td>43.85%<\/td>\n<\/tr>\n<tr>\n<td>FIIs<\/td>\n<td>4.06%<\/td>\n<td>4.23%<\/td>\n<td>15.11%<\/td>\n<td>14.90%<\/td>\n<td>15.07%<\/td>\n<td>15.55%<\/td>\n<td>15.57%<\/td>\n<\/tr>\n<tr>\n<td>DIIs<\/td>\n<td>0.95%<\/td>\n<td>0.96%<\/td>\n<td>1.46%<\/td>\n<td>3.65%<\/td>\n<td>4.02%<\/td>\n<td>4.76%<\/td>\n<td>5.17%<\/td>\n<\/tr>\n<tr>\n<td>Public<\/td>\n<td>46.38%<\/td>\n<td>45.79%<\/td>\n<td>39.57%<\/td>\n<td>37.60%<\/td>\n<td>37.06%<\/td>\n<td>35.81%<\/td>\n<td>35.40%<\/td>\n<\/tr>\n<tr>\n<td>No. of Shareholders<\/td>\n<td><\/td>\n<td>2,17,743<\/td>\n<td>2,13,123<\/td>\n<td>1,98,382<\/td>\n<td>1,88,447<\/td>\n<td>2,07,937<\/td>\n<td>2,37,377<\/td>\n<td>2,54,699<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2025-2030_Forecast\"><\/span>Marksans Pharma Share Price Target 2025-2030 Forecast<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 446px;\" width=\"466\">\n<tbody>\n<tr>\n<td>Year<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>2025<\/td>\n<td>228<\/td>\n<\/tr>\n<tr>\n<td>2025<\/td>\n<td>276<\/td>\n<\/tr>\n<tr>\n<td>2026<\/td>\n<td>293<\/td>\n<\/tr>\n<tr>\n<td>2027<\/td>\n<td>334<\/td>\n<\/tr>\n<tr>\n<td>2028<\/td>\n<td>370<\/td>\n<\/tr>\n<tr>\n<td>2029<\/td>\n<td>400<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>450<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2025\"><\/span>Marksans Pharma Share Price Target 2025<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 704px;\" width=\"554\">\n<tbody>\n<tr>\n<td>Months<\/td>\n<td>Target Prices<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>235<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>240<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>230<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>237<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>244<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>240<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>248<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>255<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>252<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>257<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>268<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>276<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2026\"><\/span>Marksans Pharma Share Price Target 2026<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 701px;\" width=\"550\">\n<tbody>\n<tr>\n<td>Months<\/td>\n<td>Target Prices<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>280<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>274<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>269<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>271<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>277<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>282<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>285<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>290<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>283<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>284<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>290<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>293<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2027\"><\/span>Marksans Pharma Share Price Target 2027<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 713px;\" width=\"554\">\n<tbody>\n<tr>\n<td>Months<\/td>\n<td>Target Prices<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>301<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>293<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>287<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>294<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>300<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>306<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>319<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>311<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>320<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>325<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>329<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>334<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2028\"><\/span>Marksans Pharma Share Price Target 2028<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 740px;\" width=\"568\">\n<tbody>\n<tr>\n<td>Months<\/td>\n<td>Target Prices<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>340<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>331<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>326<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>330<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>337<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>344<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>350<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>357<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>363<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>360<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>364<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>370<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Read More:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/jupiter-wagons-share-price-target\/\"><u>Jupiter Wagons Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/asian-paints-share-price-target\/\"><u>Asian Paints Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2029\"><\/span>Marksans Pharma Share Price Target 2029<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 708px;\" width=\"607\">\n<tbody>\n<tr>\n<td>Months<\/td>\n<td>Target Prices<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>363<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>355<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>350<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>357<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>364<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>370<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>374<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>380<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>384<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>389<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>394<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>400<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Target_2030\"><\/span>Marksans Pharma Share Price Target 2030<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 736px;\" width=\"710\">\n<tbody>\n<tr>\n<td>Months<\/td>\n<td>Target Prices<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>415<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>402<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>393<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>396<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>405<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>414<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>420<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>429<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>423<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>430<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>440<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>450<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Final_Words\"><\/span>Final Words<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Marksans Pharma ltd. company, which was just recently listed on stock exchanges, has performed poorly. Anyway the offer costs are being expanded yet the interest for shares has not been affected in that capacity. The company has been performing its core functions to the satisfaction of customers for a number of years. The company&#8217;s core functions are related to the pharmaceutical industry and the manufacturing and retailing of needed medicines, which has created a demand for such businesses.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marksans Pharma is a pioneer in the pharmaceutical industry thanks to its customer-first approach. Marksans has made a name for itself in competitive regulatory markets by focusing on both prescription and over-the-counter medications. Indian pharmaceutical company Marksans Pharma Limited As its primary activity, it is involved in the production and distribution of pharmaceutical formulations for &#8230; <a title=\"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\" class=\"read-more\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\" aria-label=\"Read more about Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\">Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":1416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1411","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stocks"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &amp; Quarterly Results - Gaainfo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &amp; Quarterly Results - Gaainfo\" \/>\n<meta property=\"og:description\" content=\"Marksans Pharma is a pioneer in the pharmaceutical industry thanks to its customer-first approach. Marksans has made a name for itself in competitive regulatory markets by focusing on both prescription and over-the-counter medications. Indian pharmaceutical company Marksans Pharma Limited As its primary activity, it is involved in the production and distribution of pharmaceutical formulations for ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\" \/>\n<meta property=\"og:site_name\" content=\"Gaainfo\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-28T03:28:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oliver\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oliver\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\"},\"author\":{\"name\":\"Oliver\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae\"},\"headline\":\"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\",\"datePublished\":\"2024-12-28T03:28:14+00:00\",\"dateModified\":\"2024-12-28T03:28:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\"},\"wordCount\":1045,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/gaainfo.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg\",\"articleSection\":[\"Stocks\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\",\"url\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\",\"name\":\"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo\",\"isPartOf\":{\"@id\":\"https:\/\/gaainfo.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg\",\"datePublished\":\"2024-12-28T03:28:14+00:00\",\"dateModified\":\"2024-12-28T03:28:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage\",\"url\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg\",\"contentUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg\",\"width\":800,\"height\":800,\"caption\":\"Marksans Pharma Share Price Target Today Update\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/gaainfo.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gaainfo.com\/#website\",\"url\":\"https:\/\/gaainfo.com\/\",\"name\":\"Gaainfo\",\"description\":\"Tech, Result, Sports, Live News\",\"publisher\":{\"@id\":\"https:\/\/gaainfo.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gaainfo.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/gaainfo.com\/#organization\",\"name\":\"Gaainfo\",\"url\":\"https:\/\/gaainfo.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png\",\"contentUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png\",\"width\":387,\"height\":320,\"caption\":\"Gaainfo\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae\",\"name\":\"Oliver\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g\",\"caption\":\"Oliver\"},\"url\":\"https:\/\/gaainfo.com\/author\/oliver\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/","og_locale":"en_US","og_type":"article","og_title":"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","og_description":"Marksans Pharma is a pioneer in the pharmaceutical industry thanks to its customer-first approach. Marksans has made a name for itself in competitive regulatory markets by focusing on both prescription and over-the-counter medications. Indian pharmaceutical company Marksans Pharma Limited As its primary activity, it is involved in the production and distribution of pharmaceutical formulations for ... Read more","og_url":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/","og_site_name":"Gaainfo","article_published_time":"2024-12-28T03:28:14+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg","type":"image\/jpeg"}],"author":"Oliver","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Oliver","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#article","isPartOf":{"@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/"},"author":{"name":"Oliver","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae"},"headline":"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results","datePublished":"2024-12-28T03:28:14+00:00","dateModified":"2024-12-28T03:28:14+00:00","mainEntityOfPage":{"@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/"},"wordCount":1045,"commentCount":0,"publisher":{"@id":"https:\/\/gaainfo.com\/#organization"},"image":{"@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage"},"thumbnailUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg","articleSection":["Stocks"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/","url":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/","name":"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","isPartOf":{"@id":"https:\/\/gaainfo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage"},"image":{"@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage"},"thumbnailUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg","datePublished":"2024-12-28T03:28:14+00:00","dateModified":"2024-12-28T03:28:14+00:00","breadcrumb":{"@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#primaryimage","url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg","contentUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg","width":800,"height":800,"caption":"Marksans Pharma Share Price Target Today Update"},{"@type":"BreadcrumbList","@id":"https:\/\/gaainfo.com\/marksans-pharma-share-price-target\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gaainfo.com\/"},{"@type":"ListItem","position":2,"name":"Marksans Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results"}]},{"@type":"WebSite","@id":"https:\/\/gaainfo.com\/#website","url":"https:\/\/gaainfo.com\/","name":"Gaainfo","description":"Tech, Result, Sports, Live News","publisher":{"@id":"https:\/\/gaainfo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gaainfo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/gaainfo.com\/#organization","name":"Gaainfo","url":"https:\/\/gaainfo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/","url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png","contentUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png","width":387,"height":320,"caption":"Gaainfo"},"image":{"@id":"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae","name":"Oliver","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g","caption":"Oliver"},"url":"https:\/\/gaainfo.com\/author\/oliver\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Marksans-Pharma-Share-Price-Target-Today-Update.jpg","_links":{"self":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1411"}],"collection":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/comments?post=1411"}],"version-history":[{"count":4,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1411\/revisions"}],"predecessor-version":[{"id":1415,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1411\/revisions\/1415"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/media\/1416"}],"wp:attachment":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/media?parent=1411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/categories?post=1411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/tags?post=1411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}